After an investigation in an adverse event, Bluebird Bio announced that it is “very unlikely” that the BB305 lentiviral vector (LVV) caused the case of acute myeloid leukemia (AML) which was ...

bluebird bio, Inc. ... bluebird bio Licenses Lentiviral Vector Patent Rights for Development and Commercialization of Cell Therapies. May 02, 2017 08:00 AM Eastern Daylight Time.

Just weeks after two unexpected cases of blood cancer landed trials of its investigational gene therapies for sickle cell disease (SCD) and beta-thalassemia on FDA-issued clinical holds, Bluebird Bio ...

Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.